Anders Ahlsson is the Director of Health Care in Stockholm. He is responsible for the health care system in the county, including finance and reimbursement models, quality and control of health care providers, and support to the political organization. With a background as a consultant and associate professor in cardiac surgery, Anders has contributed significantly to various European guidelines in cardiology and cardiac surgery, participating as a task force member. Currently, his primary areas of focus include leadership, strategic decision-making, and judgment. In addition to his duties in Stockholm, Anders is actively involved in national committees related to healthcare and education.

Rob Allen is the president and CEO of Intermountain Health, a leading nonprofit health system headquartered in Utah with locations in six states and operations across the western U.S. In 2023, Modern Healthcare named Rob as one of the 100 Most Influential People in Healthcare. Rob has served in executive leadership roles at Intermountain for 28 years of his 30+ year health leadership career. He is a nationally recognized leader in advancing value-based care and has multiple achievements around advancing rural health, telehealth, affordability, and continuous improvement. Prior to beginning his role as president and CEO in November 2022, Rob served as chief operating officer for five years. He was named as one of the top 25 COOs in healthcare by Modern Healthcare. He has also held CEO roles at hospitals and health systems in Wyoming, New Jersey, and Massachusetts. Rob earned a Master of Business Administration degree from Utah State University and a Bachelor of Science in operations management from Brigham Young University. He was also awarded an honorary Doctor of Science degree by Rocky Vista University. Rob’s love of healthcare began during his childhood as he was raised on a farm in rural Wyoming, where his mother served as a nurse and later as administrator at Star Valley Hospital. Rob and his wife, Becky, have three children and six grandchildren.

Medical School: Hebrew University, Hadassah Residency: Hadassah University Hospital Fellowship: Gynecologic Oncology (NYU), Jerusalem, Israel, New York University Medical Attending Physician: NYU medical Center Chairman: Dept of Gynecology, Share Zedek Medical Center President: Israeli Society of Gynecologic Oncology President: ESGO European Society of Gynecologic Oncology Editor in Chief: The International Journal of Gynecological Cancer Center.

Maurice van den Bosch (1974) studied Biomedical Health Sciences (MSc) and Medicine (MD) at the Radboud University Nijmegen, the Netherlands. He finished his PhD-thesis in the field of Epidemiology at the University of Utrecht in 2001, and became a resident in Radiology at University Medical Center (UMC) Utrecht (2002 – 2007). He did a postdoctoral fellowship Interventional Radiology at Stanford Medical Center (2007-2008) USA. In 2009 he obtained a faculty position as Interventional Radiologist in UMC Utrecht. He was appointed Professor of Interventional Radiology in 2011. Maurice van den Bosch currently published >200 peer reviewed manuscripts in the field of cancer imaging and interventions. He is member of several international advisory boards, including CIRSE Foundation Advisory Coucil and European School of Radiology (ESR) Leadership Institute. In 2014 he became Chairman of the department of Radiology and Nuclear Medicine in UMC Utrecht, and was appointed Medical Director of the Center for Image Sciences, UMC Utrecht. In 2017 he became member of the Executive Board OLVG hospital Amsterdam and per April 2018 he was appointed Chairman of the Board of Directors.

Maurice will take up the position of Chairman of the Execituve Board of the Netherlands Cancer Institute on January 1, 2024.

Michel Calmon has a doctorate in law and a diploma of Bordeaux political studies institute. He is also graduated from Public health high studies school. He is former Universitary hospital CEO of La Reunion and former CEO of Fondation Santé Service, Main Hospital at Home organization in France. He is member of the board of French hospital at home federation. He is teaching HAH at Leonard de Vinci University in Paris.

Dr. Anke Diehl, M.D., M.A., is Chief Transformation Officer and Head of the Digital Transformation Unit at the University Medicine Essen (UME). As a medical doctor with broad clinical and scientific experience (neurology, psychiatry, neuroradiology and radiology), she is responsible for implementing innovative projects as part of the smart hospital’s digitization strategy. Prior to her position as Digital Change Manager of UME, she was head of the department of health care structure development in one of the subordinate divisions of the Ministry of Health NRW (LZG.NRW). The expert for digital medicine has been consortium leader of the leading edge cluster of artificial intelligence in medicine “SmartHospital.NRW“ since March 2021. She is a member of numerous committees, such as the scientific advisory board of Medizin.NRW, the board of SMITH (Smart Medical Information Technology for Healthcare/German Medical Informatics Initiative) and the medical advisory board to accompany the development of a telematics infrastructure for healthcare in NRW. End of 2021, Dr. Diehl was appointed by the German Federal Ministry of Health and the Gematik to the 7-member National Expert Panel “Interop Council” and won the „Medical Woman of the Year 2021“ award (German Medical Awards). She is also member of the Expert Panel „Ausschuss Digitalisierung in der Gesundheitsversorgung“ of the German Federal Medical Association.

Beccy Fenton MA OXON ACA, has a degree in Engineering Science from Oxford University, she is a qualified charted accountant ACA, a qualified coach and a Lean practitioner.

Beccy has worked predominantly with the public sector for over 25 years. Her career includes 4 years at PWC in Audit where she trained to become an accountant, 14 years in the NHS including 10 years where Beccy was an NHS Executive Board Director holding the positions of CFO, Hospital Managing Director, Director of Strategy & Transformation and the last 12 years at KPMG in the Infrastructure, Government and Healthcare (IGH) business predominantly in management consulting and latterly in Markets.

During her time in the NHS Beccy ran the following departments: Finance, IT, Estates, Procurement, Business Development and Transformation. Beccy’s NHS organisation was awarded “Hospital of the Year” when Beccy was CFO. Beccy led the first ever NHS M&A transaction and has led several NHS turnaround programmes.

At KPMG Beccy is currently Head of Infrastructure, Government and Health. Prior to this she was Head of Health and led the healthcare business during the Covid-19 pandemic where KPMG provided significant support to the UK Government, NHS and private healthcare organisations. Beccy has extensive experience in developing and implementing growth strategies for KPMG as well as experience in management consulting in a number of areas including working with Governments and Public and Private organisations to support them with strategy, target operating model redesign, performance improvement, cost reduction, M&A and health and care service redesign.

Beccy is also KPMG’s Global Head of Care System Redesign and she works across KPMG’s global network to share best practice, drive innovation and support global Governments and public sector clients improve and transform.

Beccy is married and has two children and in her spare time likes water sports, snow skiing and travel.

Alan J. Forster MD, FRCPC, MSc is the Vice President, Innovation, Transformation, and Clinical Performance at the McGill University Health Center and the McGill University Professor for Health Innovation. His focus is enabling teams to create higher value health care – in which patient outcomes are realized and health system costs are lowered. Over his career, he has led local, national, and international efforts to improve healthcare quality. His research programs have contributed to over 240 publications in peer review journals and innumerable advances in quality. Lasting contributions include his impact on the development of a model for learning health systems leveraging healthcare data. In recognition of his contributions, he was listed as one of Canada’s top 10 healthcare power brokers by Maclean’s Magazine in April 2023 and named to the International Society for Quality in Healthcare’s International Academy for Quality and Safety in Healthcare in July 2023.

Melanie is the Director of the Western Australian Country Health Service (WACHS) Command Centre. A technologically enabled Service, providing 24/7 access to specialist for clinicians and communities across the largest health Service, by land mass, in the world. The WACHS provides care across 2.55 million square kilometres, to more than half a million people, with approximately 11% of this population identifying as Aboriginal. Melanie trained as a critical care nurse in the UK before travelling to Western Australia and falling in love with the vast distances and diversity found in this state. Having lived and worked in some of the most remote places in the state, she now leads the Command Centre, which includes clinical specialists in Emergency, Mental Health, Midwifery, Palliative care, In-patient, education and patient transfer coordination as well as a senior team who provide organisation wide situational awareness, emergency management and escalation coordination.

Dr. Halamka is an emergency medicine physician, medical informatics expert and president of the Mayo Clinic Platform, which is focused on transforming health care by leveraging artificial intelligence, connected health care devices and a network of partners. Dr. Halamka has been developing and implementing health care information strategy and policy for more than 40 years. Previously, he was executive director of the Health Technology Exploration Center for Beth Israel Lahey Health, chief information officer at Beth Israel Deaconess Medical Center, and International Healthcare Innovation Professor at Harvard Medical School. He is a member of the National Academy of Medicine.

Boubou Hallberg M.D Ph.D is CEO at Sahlgrenska University Hospital in Gothenburg, Sweden. He is specialist in pediatrics and neonatology and was head of department at the Karolinska University Hospital. He has a vast experience as a senior healthcare  executive in different roles both national and international from distinguished institutions.

Healthcare is undergoing a transformation. Sahlgrenska University Hospital, which is Sweden’s largest hospital, has started the journey towards the goal of Europe’s leading university hospital in 2032. Together with patients and employees, Sahlgrenska University Hospital is transforming healthcare for a sustainable future.

Guy Hans got his medical degree at the University of Antwerp in 1995. He specialized in anesthesiology and received his board certification in 2000. Following that, he started as a staff member in the multidisciplinary pain center of the Antwerp University Hospital (UZA). After a few years, he was appointed as the medical coordinator of largest pain center in Belgium. In 2015 he was appointed as the Chief Medical Officer of the Antwerp University Hospital, a position which he still holds to this day. In addition, he works at the Belgian National Institute for Health and Disability Insurance (NIHDI) as a scientific evaluator. Besides that, he has several positions within boards of hospitals and scientific committees at a national and international level, serving currently as the president of the Belgian Pain Society (BPS). During the last 10 years, he has acquired a special interest and specialization in the digitalization of health care and remote monitoring and caring for patients. As such, he has been responsible for the development of the UZA@home program, which is by far the largest fully integrated service for remote monitoring, virtual care and home hospitalization in Belgium.

Sir Julian joined NHS Providers as chief executive in February 2023, having been chief executive of Leeds Teaching Hospitals since 2013. NHS Providers is the membership organisation for the NHS hospital, mental health, community and ambulance services that treat patients and service users in the NHS. We help those NHS foundation trusts and trusts to deliver high-quality, patient-focused care by enabling them to learn from each other, acting as their public voice and helping shape the system in which they operate. NHS Providers has all trusts in England in voluntary membership, collectively accounting for £115bn of annual expenditure and employing 1.4 million people. During his decade of service at Leeds, Julian led a major programme of culture change and staff engagement to deliver improved quality, operational and financial performance. In 2019 Julian was asked by Baroness Dido Harding, Chair of NHS Improvement, to be the executive lead for the interim NHS People Plan. He previously worked as managing director of NHS Improving Quality – a national organisation set up to drive change and improvement across the NHS. Julian’s career in the NHS began as a general management trainee working in the North East of England. Following his training, he worked in a number of NHS management posts at hospital, health authority and regional level. His first board director appointment was at North Tees and Hartlepool NHS Trust, where he was responsible for planning, operations and strategy. Julian led Tameside and Glossop Primary Care Trust (PCT) as chief executive for three years, where he took it to three-star status, developed new Primary Care Centres and managed the PCT’s involvement in the Shipman Inquiry. From 2005, Julian was chief executive of Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust, seeing the trust transform and go on to achieve major financial turnaround, secure Foundation Trust status and become one of the first trusts in the country to meet 18-week targets. In addition, Julian chaired the North West Leadership Academy. Julian was appointed chief executive of University Hospital of South Manchester NHS Foundation Trust in June 2009 and led a major turnaround in MRSA reduction, and 18 week performance. He also introduced a major programme of cultural change to improve patient experience and outcomes. Julian was awarded Knight Bachelor for services to healthcare in the 2022 Queen’s Birthday Honours.

Erik is Senior Vice President and National Practice Lead for Value Based Care. He has broad experience in designing population health strategies for a broad array of providers. At Optum, he leads clients through the process of developing new value-based care strategies and operating models that rely on the sharing of risk between payers and health systems; the development of Medicare ACO and Medicare Advantage strategies; and the design and development of post-acute care networks.  In addition, Erik has extensive experience working with the National Health Service (NHS) in the United Kingdom as the NHS transitions its operating model toward one that is based on integrated care models and Triple Aim objectives.

He was most recently Senior Vice President at Avalere Health, where he ran its Healthcare Networks consulting practice and oversaw new product development. Erik assisted healthcare systems in determining how to adopt and assess accountable care and bundled payment models, and guiding overall strategy. Erik also worked with health IT companies in responding to emergent issues around EHRs and data exchange.

Prior to joining Avalere, Erik Johnson was a Managing Director with Manatt Health Solutions, leading long-term customer engagements focusing on the application of health IT to clinical challenges and opportunities. He previously spent five years at the Advisory Board Company as Managing Director for its health IT and hospital finance research practices, respectively. From 1998-2003, Erik served in various management and executive capacities at MicroStrategy. He started his career in health care in 1992, as deputy branch chief for Health Finance in the Office of Management and Budget.

Erik has an BA with honors and distinction from Stanford University and an MBA from the Stanford Graduate School of Business.

Ruthy leads Microsoft’s Healthcare Business across Europe, Middle East & Africa (EMEA), focusing on Health Providers and Payors, covering >120 countries. In her role, Ruthy works with Ministries of Health, Public and Private Health Providers, Health Payors, and Hospitals across the region helping them transform their organizations with technology and digitalization, with the aim to bring better healthcare experiences and better care.
Ruthy has been with Microsoft for over 10 years, and previously led Microsoft’s Healthcare business across Central, Eastern Europe & Middle East-Africa, was Microsoft’s Chief Startups Lead and Software Partners Tech Lead in Central & Eastern Europe, and prior to that, served as the Vice President for Startups & Developer Relations at Microsoft Israel, as part of the Microsoft Israel Leadership team.
Ruthy Kaidar is an executive with over 25 years of experience in the Software, Health-Tech, Medical Devices, Telecommunications, and Venture Capital Industries. As a Computer Science Engineer, she worked in Software and Firmware engineering. She then followed her passion for Healthcare and turned to Brain Research, pursuing a Master’s degree in Biomedical, Mechanical & Electrical Engineering, focusing on Brain Computer Interfaces.
Ruthy held key positions in R&D, Project and Product Management, and Business
Development in Med-Tech companies, among them Medingo, which she joined from founding to acquisition by Roche (for $200M). She founded and chaired several Internet and Digital Health startups, served as a business consultant to Health-Tech and Services companies, and was an Entrepreneur In Residence in Venture Capital, focusing on Digital Health investments.
Ruthy holds a BSc in Computer Science, MSc in Mechanical Engineering & Brain Research, and an MBA, all cum laude, from the Technion, Israel. Ruthy lives with her family in Israel, loves yoga and running, and traveling the world.

Anwer is a healthcare and life sciences technology consulting leader with a track record of launching and growing large-scale technology-based practices and market offerings across healthcare ecosystems. He helps organizations to capitalize on emerging and disruptive technologies, cloud-based/digital solutions, and agile consumption and delivery models.

As Global Healthcare Sector Technology Leader for KPMG International, he leads and collaborates with a global network that creates digital solutions to help address critical challenges and support transformation in healthcare organizations in agile, secure, and scalable ways.

As Partner, Advisory, Customer and Operations, Health and Government, for KPMG in the U.S., Anwer is focused on developing IT-enabled solutions that help his clients to achieve meaningful clinical and operational transformation.

Anwer holds several registered patents in the United States in the areas of health data management and advanced analytics. He is also a frequently published author and speaker on pressing technology topics.

Dr. Klasko is an author, an entrepreneur and a believer in the creative and optimistic transformation of healthcare and higher education. He has been a health system CEO, a university president, and a dean of two medical colleges. Currently he is pursuing his passion to bridge academic health centers with the emerging world of generative AI, digital medicine and innovation. As President of Thomas Jefferson University, he directed a merger between an almost two century old health science university and a nationally ranked university for design and architecture. That merger was heralded by the Chronicle of Higher Education as one of the “few successful mergers between academic entities.” As CEO of Jefferson Health, he presided over the growth of the system from $1.5 billion to $9 billion including the acquisition of Health Partners Plan, making Jefferson the first integrated delivery and financial system in Philadelphia history and the largest health system in Philadelphia. This included a first of its kind digital “health at any address” partnership between Jefferson and leading health venture capital firms such as General Catalyst, a16z and Oak HC. He has been a board member and advisor to several AI behavioral health entities and led the Forbes Health Summit this year on the ethical and regulatory “unintended consequences” of generative AI. His most recent book, Feelin’ Alright: How the Message in the Music Can Make Healthcare Healthier uses music and creativity to tackle the biggest issues in healthcare His fifth book (with Hemant Taneja of General Catalyst) in 2021, UnHealthcare: A Manifesto for Health Assurance has become the manual for both founders and health system CEOs for merging the venture capital world with the traditional healthcare ecosystem. Dr. Klasko serves as Executive in Residence at General Catalyst, North American ambassador for Sheba Medical Center in Israel, and as CMO and Operating Partner of Abundant Partners. He is the lead independent director for Teleflex (TFX:NYSE), a multi-billion dollar medical device company. In 2022, President Biden appointed him to the National Board of Education Sciences. He serves as a member of the Founders Circle for BrightEdge, a unique impact investing arm of the American Cancer Society. Dr. Klasko is also the board chair of Opera Philadelphia and a trustee of Rosalind Franklin University and Chicago Medical School. Over the past five years he has been awarded by Fast Company as one of the “top 25 most creative people in business,” by Modern Healthcare as the “#2 most influential person in healthcare” and by Ernst and Young as the “entrepreneur of the year.” He lives in Miami and New York with his wife Colleen Wyse, a commercial model and former fashion executive with senior positions in Vogue, W and Glamour.

Ernst Kuipers has extensive experience in healthcare, medical research, and government. He will serve as Vice-President Research for Nanyang Technological University in Singapore. Ernst previously served as Minister of Health, Welfare and Sport of The Netherlands. He focused on a broad integrated care agenda to improve access, clinical outcomes, and workforce satisfaction. Before, Ernst long served Erasmus MC University Medical Center in Rotterdam, the Netherlands as CEO, Professor of Medicine and Department Chair. As CEO, he led the transformation to a new ‘smart’ hospital that forms part of the European University Hospital Alliance. Ernst was a Member of the Governing Board of the National University Health System in Singapore and Board member of Curacao Medical Center. He further acted as Chair of the Dutch National Emergency Medicine Network, which played a major role during the covid pandemic. Ernst earned a medical degree, and then completed training in Internal Medicine and Gastroenterology in the Netherlands. He subsequently worked at Vanderbilt University Medical Center, Nashville, TN, and then joined Erasmus MC.

Professor Kenneth Kwek has been the Chief Executive Officer of Singapore General Hospital (SGH) since May 2017, and concurrently serves as Deputy Group Chief Executive Officer (Digital Health), SingHealth. SGH is the longest standing hospital in Singapore and traces her history to 1821.  The committed team in SGH delivers advanced tertiary and quaternary level clinical care to over 1 million patients every year and is a proud member institution of the SingHealth cluster.

Prof Kwek received his MBBS degree from the National University of Singapore in 1989. He trained in KK Women’s and Children’s Hospital (KKH) and obtained his Master of Medicine (O&G) in 1995.  He was admitted as a member to the Royal College  of  Obstetricians  and  Gynaecologists  as well as the Royal Australian College  of  Obstetricians  and  Gynaecologists  in  1995.

He subspecialized in High-Risk Obstetrics and undertook a yearlong fellowship in perinatal medicine in the John Hunter Hospital in Newcastle, Australia. His clinical focus and research interests were on preterm labour, cervical incompetence, post-partum hemorrhage and pre-eclampsia.  Prof Kwek assumed the headship of the Peripartum Unit in KKH and was subsequently named as the Head of the Department of Maternal Fetal Medicine between 2006 and 2012.  Prof Kwek has been passionate about Academic Medicine and value-based healthcare, being strongly committed to making a positive impact for patients.

He completed his Executive MBA in SMU in 2012 and undertook greater leadership and management responsibilities.  He was Chairman of the Medical Board of KKH between 2009 and 2012 before being named as CEO, KKH between 2012 and 2017.

He is focused on improving the quality of patient care and harnessing process re-engineering, innovation and technology to enhance the safety and reliability of clinical care and patient outcomes, while also elevating the experience for patients and healthcare staff.  In his role overseeing Digital Health across SingHealth, Prof Kwek is committed to leveraging digital technologies and emerging data structures and architecture to enhance care, to elevate experience by patients and caregivers alike and to extract greater value from the healthcare system.

Dr. Lukas Kwietniewski currently holds the position of Director of Health Care Analysis at Statista. In this role, he leads a team of analysts and data scientists focused on compiling data-driven rankings of hospitals, nursing homes, and other health care providers around the globe. The rankings are crafted based on a comprehensive analysis of publicly available data encompassing hospital quality metrics, patient satisfaction, and surveys of medical professionals conducted by Statista and Newsweek on a global scale.

Dr. Kwietniewski is leading the expansion of Statista’s hospital rankings, most notably the development of the prestigious World’s Best Hospitals ranking, which now extends to 30 countries worldwide. This ranking includes data from a questionnaire on the implementation of Patient Reported Outcome Measures (PROMs), which hospitals can submit directly to Statista. The PROMs implementation score will be integrated into all upcoming Statista hospital rankings.

Prior to joining Statista, he contributed his expertise at the BQS Institute, a distinguished private research institute in Germany. In this capacity, he was involved in various projects, notably overseeing quality assurance and health economics initiatives in hospitals, nursing homes, and rehabilitation facilities throughout Germany.

An alumnus of the esteemed Hamburg Center for Health Economics, Dr. Kwietniewski conducted scientific research on the cost and economic efficiency of health care providers. His research further revolved around international comparisons of health care and hospital utilization, showcasing his commitment to advancing the field of health economics.

Marcel Levi is president of the Dutch Research Council and currently vice-president of Science Europe. Previously he was chief executive of the Academic Medical Center in Amsterdam where he initiated the merger with the Free University Medical Center to Amsterdam University Medical Center. Thereafter he was chief executive of University College London Hospitals in the UK. He is professor of Medicine at Amsterdam University Medical Center/University of Amsterdam and University College London and a specialist in Internal Medicine and Haematology. Earlier he worked at the University of Perugia (Italy), in Oxford (UK) and at the Center for Transgene Technology and Genetherapy of the University of Leuven (Belgium). He has published over 800 research articles in international journals and is (associate) editor of various scientific journals. He is currently chairman or board member of several national and international research and health care organisations and charities. He is a member of the Royal Netherlands Academy of Science and Fellow of the Royal College of Physicians. He is editor of various scientific journals and author of many popular/scientific/educational books and columns.

Christoph A. Meier is Director of the Department of Internal Medicine at the University Hospital Zürich and holds a faculty appointment at the University of Geneva. He has a longstanding interest in the evaluation and improvement of quality in health care and is/was serving among others on the Expert Board for Newseek’s Best Hospitals of the World, the Swiss Medical Board for HTA and the Swiss Federal Quality Commission.
Prior to his current role, he was the Chief Medical Officer and deputy CEO at the University Hospital Basel, where he implemented the principles of value-based health care and PROMs as key tools for quality and performance management. Previously, held the position as the Chief of Medicine at the Triemli Hospital in Zürich and was heading the Clinical and Molecularl Endocrinology Unit at the University Hospital Geneva, Switzerland.
He received his Medical Degree from the University of Basel, Switzerland and holds Board Certifications in Internal Medicine and Endocrinology & Diabetology and worked at the University Hospital Geneva, the National Institutes of Health (USA), the Brigham and Women’s Hospital and the Massachusetts General in Boston.

Dr. Itamar Offer is a Healthcare management professional (Medical Doctor) with 25 years of experience at senior positions in hospitals and community healthcare. Of those 8 years in the Israeli Public Healthcare, 4 years in India’s private healthcare and 5 years as CEO at Herzliya Medical Center. Most recently, Dr. Offer was the CEO and Chairman of Sabar Health Ltd, Israel’s largest “Hospitalisation at Home” organization. Dr. Offer is the Founder and Co-Chair of the World Hospital at Home Congress and Community. Dr. Offer has a medical degree from Tel-Aviv University, and Masters in Public Administration (MPA) degree from Harvard Kennedy School. He is a specialist in Pediatrics and in Healthcare Management.

Karen Oldfield served for more than 18 years as President and CEO of the Halifax Port Authority where the organization saw record level growth in investments and expansion translating to a significant increase in trade activity for the region. Under her leadership, Halifax became the first port in Canada to achieve the internationally recognized standard for environmental management systems earning the ISO14001 certification.

Since September 2021, Karen has acted as the Interim President and CEO of Nova Scotia Health (NSH) by appointment of Premier Tim Houston. With over 40,000 employees, Nova Scotia Health is the largest employer in Nova Scotia, responsible for operating the provincial healthcare system. Karen has been tasked with leading the organization’s transformational efforts and to take immediate action to improve health care in Nova Scotia. This transformation includes major province-wide infrastructure, including the biggest capital project/spend in Nova Scotia’s history, the installation of a province-wide technology backbone supporting the entire acute care system, the creation of the Nova Scotia Innovation Hub where researchers, clinicians and entrepreneurs come together to innovate creative solutions.

Umang has a deep understanding of the nuances between AI and healthcare, having worked on the frontline of digital health innovations. With hands-on experience spanning both the commercial and public sectors of healthcare, he’s keenly aware of the potential that AI offers in enhancing patient care and streamlining processes. An NHS Leadership Academy Fellow and active clinician at Frimley Health, Umang has also contributed to Babylon Health’s pioneering efforts in AI health services. Today, as the Chief Clinical Information Officer for Microsoft UK, he combines his clinical insights with technological ability to ensure that AI tools are both advanced and applicable in real-world healthcare settings.

As Global Head of Healthcare, Anna leads the KPMG healthcare network of 5,000 professionals who provide Audit, Tax and Advisory services to healthcare organizations in more than 70 countries and territories around the world. Anna is a trusted advisor to health leaders ranging from ministers of health, hospital CEOs and executives of payor organizations across six continents. She draws on more than 30 years of experience in diverse senior managerial, board, and consultancy roles in the sector. She understands the complex nature of the sector and brings not only a bold vision for the future of health but also the experience to execute on transformation initiatives. Anna is the author of several KPMG International publications on topics that include future scenario’s for healthcare systems, organizational transformation, health equity, sustainability and resilience, value-based healthcare, out of hospital care provision, and technology-enabled care delivery systems. She is a well-regarded keynote speaker at international events covering topics that include healthcare system effectiveness and resilience, digital transformation and health equity. Anna sits on the Steering Committee for the Partnership for Health System Sustainability and Resilience, a global collaboration between the World Economic Forum, the London School of Economics, AstraZeneca, Royal Philips, KPMG, Apollo Hospitals and the Center for Asia-Pacific Resilience and Innovation. Prior to her appointment as Global Head in 2020, Anna was Head of Healthcare for KPMG in the Netherlands, where she founded and grew the firm’s healthcare advisory business. In this role, she supervised a number of successful national and regional transformation programs based on design and implementation of new service delivery, reimbursement and governance models and physical infrastructures. Anna was also global lead for KPMG’s Care System Redesign proposition group, in this capacity she worked extensively with clients to transform and help futureproof care systems. Before joining KPMG in 2011, Anna held senior-level positions at several hospitals and academic health sciences centers, where she led and executed transformations. As CEO of the Dutch Diagnosis Related-Groups (DRGs) and Pricing Office, Anna was a major force behind the adoption of DRG systems for providers and the introduction of a new national healthcare payment system. Anna has a PhD in Economic Sciences from Erasmus University Rotterdam. She is fluent in English, French, German and Dutch.

Having experienced her first symptoms of Parkinson’s disease at age 13, Sara Riggare now, 40 years later, utilizes her patient experiences and her academic training to conduct research that is truly patient-centered. She has made it her mission to bring patients, researchers, healthcare, industry, and policymakers closer together to improve health for all. In 2022, Sara became the first person in the world to earn a PhD with a thesis on personal science. She is a well-known patient leader, highly appreciated speaker, and was named Swede of the year in medicine 2018. Sara advises, among others, the British Medical Journal, the Swedish Medical Products Agency, the Swedish National Board for Health and Welfare, and the Swedish Governmental Agency on Innovation Systems.

Ido is a partner at KPMG and leads the digital transformation and artificial intelligence departments, where major technological projects are carried out in Israel and abroad under his management. Over the years, Ido has led the largest projects in the world that dealt with the implementation of edge technologies, those that touch the entire width of an organization and change the way it is conducted. Before KPMG, Ido led the field of artificial intelligence at IBM where he dealt with the technology itself and saw the needs of the customers in front of the technological capabilities. Ido started his career as a developer and led development teams at Intel.

Dr. Eran Rotman M.H.A M.D is a Family physician, who served throughout the years in both community & hospital management leading roles. He was the General Director of Beilinson hospital during the COVID pandemic. He is now the Deputy CEO & head of Health division, Maccabi Health Services, in charge of the entire community medical services 0f 2.7 M patients. He is an expert in Community- Hospital Continuity of care, Home Hospitalization and Public health Management during crisis.

As senior vice president of community and population health, Debbie Salas-Lopez, MD, MPH, oversees Northwell Health’s community and public health strategy, including community health equity, community relations, strategic community partnerships, corporate social responsibility, and the Community Health Needs Assessment. Dr. Salas-Lopez’s leadership was critical during the COVID-19 pandemic. She and her team partnered with many community and faith-based leaders to identify their most-pressing needs. This became the catalyst for the creation of Northwell’s Health Equity Taskforce composed of more than 100 community, faith, and tribal nation leaders that today continue to work on equity and social issues that impact health. Dr. Salas-Lopez joined Northwell in 2019 as senior vice president for transformation, responsible for system value-based initiatives that improve health and care delivery. She assumed her leadership role after serving as the chief transformation officer at Lehigh Valley Health Network, where she led strategy and oversaw a unique and broad portfolio, including community-based and population health initiatives, telehealth, connected care, and innovation, strategic partnerships, and operational redesigning of the clinical delivery system. Dr. Salas-Lopez is a nationally recognized speaker and educator on women leaders, healthcare disparities and equity in care, cultural awareness and language-appropriate services, and the impact of social and economic factors on health. In 2021, Modern Healthcare named her to its annual Top 25 Women Leaders as a “Woman to Watch.” She also received the 2021 Tribute to Excellence in Health Care award from the United Hospital Fund. Dr. Salas-Lopez was recognized in 2021 by the Hospital Association of New York State with a Community Health Improvement Award. She also has earned a Hispanic Chamber of Commerce Leadership Award, the Long Island Coalition for Homeless Key of Excellence Award and the 2021 Empire Whole Health Heroes Award.

Melvin Samsom has a distinguished career, both as a gastroenterologist, a scientist and as an administrator. Currently, he serves as a non-executive director of Bupa, a global health insurance and healthcare provider spanning five continents. Additionally, Melvin chairs the supervisory committee overseeing the Reorganization of the Academic Care Landscape for the Dutch Ministry of Health and holds the position of Chair of the supervisory board at the Oncode Institute. He also serves as a Senior National and International Advisor for KPMG Health. Melvin has been honored with a prestigious personal grant from the Royal Netherlands Academy of Arts and Sciences. His research experience extends to institutions such as the Royal Adelaide Hospital in Australia, the Mayo Clinic in the United States, and the University Medical Center Utrecht in the Netherlands. Previously, Melvin Samsom served as the Chief Executive Officer of Karolinska University Hospital in Sweden, where his leadership ushered in a groundbreaking operating model centered around the patient journey. Under his guidance, the commissioning of one of the largest and most technologically advanced hospital buildings was successfully completed. Prior to his tenure in Sweden, Melvin held the positions of CEO and CMO at the Radboud University Medical Center in the Netherlands, orchestrating a significant organizational turnaround. More recently, he crafted the Health, Wellbeing, and Biotech strategy for NEOM, aspiring to establish the healthiest place in the world. This strategy emphasizes proactive prevention and world-class treatment of diseases. Melvin has also contributed as a Senior International Advisor to the Health Holding Company and has been a member of several Health Clusters in Saudi Arabia.

Arthur Schellekens is chief executive officer of the Dutch Patient Federation, an advocacy organization with circa 90 professionals representing more than 200 patient organizations. The Federation is committed to all people requiring healthcare, now and in the future. It gives patients a voice: in the consulting room, in policy making, in research activities and in the politics by advising, actively cocreating with stakeholders and by lobbying activities. By gathering and analyzing individual experiences of patients, the Dutch Patient Federation is bridging the gap between patients’ needs and the healthcare offered. Part of this effort is to provide patients with a comprehensive, yet easy-to-understand information thereby helping them make informed choices. Arthur Schellekens (1970) is an experienced and dedicated officer with expertise in managing non-profit organizations with a bit of a business slant. He has been director of the Dutch Association of Youth Care and Child Protective Services, the Dutch Association of Public Libraries and the Royal Dutch Association of Realtors (amongst others). Arthur has a Master’s degree in Public Administration. He is a practical person, realizing that only collaboration and co-creation can lead to truly meaningful and long-term results.

Munjal Shah is the co-founder and CEO of Hippocratic AI, a startup building the first safety-focused large language model (LLM) for healthcare. The company is on a mission to dramatically improve healthcare access, equity and outcomes through the use of generative AI. Munjal is a serial entrepreneur, startup adviser, and investor. He was co-founder and CEO of an AI company that was acquired by Google and a marketplace management, research and analytics company eventually sold to Alibaba. He graduated from Stanford with a Masters in Computer Science, focused on AI. Prior to Hippocratic AI, Munjal spent 10 years as co-founder and CEO of a healthcare startup leveraging AI to analyze health records to help seniors select the best Medicare Advantage plan.

Managing Director, Health City Cayman Islands, Cayman Islands

Lisa is the Executive Director in the Pilbara for Western Australia Country (WACHS) and has lived and worked across many parts of the vast rural and remote areas of Western Australia.  The Pilbara region is Western Australia’s second most northern region, defined by the Indian Ocean to the west and the Northern Territory border to the east. The region covers a total area of 507,896 sq km (including offshore islands).  The Aboriginal culture of the Pilbara is proud and diverse with as many as 31 languages and dialects spoken by coastal and desert peoples across the region.

Lisa is responsible for seven hospitals, two remote nursing posts, a community mental health and a Public health service and leads a multidisciplinary team of medical, nursing, allied and population health staff to deliver compassionate and inspirational health services across diverse rural, remote, and urban health settings. Devoted to delivering contemporary and culturally responsive healthcare, she is a catalyst for positive change and is unwavering in her commitment to patient safety.

As a visionary leader, Lisa excels at initiating transformative initiatives and cultivating collaborative teams to deliver efficient, consistent, and safe healthcare services. Throughout her career, Lisa has been a beacon of influential stakeholder engagement, forging close collaborations with executive teams, government agencies, and community organisations to elevate health outcomes. A recognised expert in remote health service management, leadership, and delivery, Lisa specialises in building effective and collaborative teams while ensuring robust governance. Her notable accomplishments include guiding organisational restructures, leading outpatient reform, implementing innovative programs, and steering responses to critical situations, including the challenges posed by the COVID-19 pandemic in remote settings.

With a dedicated focus on nurturing future leaders, Lisa aspires to make a lasting positive impact in healthcare and champion women in leadership and governance.

Shai-Lee has taken key positions in the Israeli High-Tech industry, gaining significant experience and knowledge for the advancement of the Government and the public sector in Israel.

Some of her previous roles include General manager at Fiverr, Director General of the Ministry of Science and Technology and Head of the Israeli National Digital initiative.

Shai-Lee has extensive experience in the High-Tech world, and has served as VP of Marketing at Microsoft’s R&D Center in Israel and was jointly responsible for building relations with the start-up industry in Israel. She has also previously served as Director of Regulation and Corporate Affairs in Microsoft Israel.

Shai-Lee has a Bachelor’s degree in Law from Tel Aviv University, and a Master’s degree in Public Policy from Harvard University in the United States.

Thea Stein is the Chief Executive of the Nuffield Trust. She took up the post in September 2023. Thea was previously Chief Executive at Leeds Community Healthcare NHS Trust, and before then Chief Executive of Carers Trust, Yorkshire Forward and North East Leeds Primary Care Trust. Thea has also held a number of non-executive roles in housing organisations and academia. Thea was a trustee of the Nuffield Trust between 2019 and 2023.

Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad led the company through 4 investment rounds bringing the total investment to $250M, drove the commercial availability of 20 product lines, created an install base of over 1,000 global hospitals while growing the company to over 400 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects.

Prof. Zimlichman serves as Chief Innovation Officer and Chief Transformation Officer at Sheba Medical Center (Sheba). To redesign healthcare to be more patient-centric, effective, efficient, and equitable, he founded Sheba’s innovation arm, ARC. ARC is short for accelerate, redesign, and collaborate. In the United States, Prof. Zimlichman held the position of lead researcher at Partners HealthCare’s Clinical Affairs Department in Boston, where he was involved in strategic care redesign efforts. During that time, Prof. Zimlichman had appointments at Brigham and Women’s Hospital and Harvard Medical School’s affiliate, the Center for Patient Safety Research and Practice. Prof. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care and an international expert at the International Society of Quality in Healthcare. He also served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services. Prior to assuming his current position, he was Chief Medical Officer and Chief Quality Officer at Sheba. Prof. Zimlichman earned his MSc in Healthcare Management from the Harvard Chan School of Public Health and his MD from the Technion Israel Institute of Technology.